262062667	262062667	CD	B-NP	O
|	|	NN	I-NP	O
EH	EH	NN	I-NP	O
|	|	NN	I-NP	O
85642623	85642623	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2255391	2255391	CD	B-NP	O
|	|	CC	I-NP	O
9/21/2004	9/21/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
cad	cad	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/14/2004	3/14/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/2004	8/5/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KLAAMEYER	KLAAMEYER	NNP	B-NP	O
,	,	,	O	O
NORMAN	NORMAN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
760-65-53-4	760-65-53-4	CD	I-NP	O
Troit	Troit	NNP	I-NP	O
Lake	Lake	NNP	I-NP	O
Lis	Lis	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/22/04	10/22/04	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DOUTHETT	DOUTHETT	NNP	B-NP	O
,	,	,	O	O
BILLY	BILLY	NNP	B-NP	O
DERICK	DERICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC+HS	AC+HS	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	B-DNA
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-DNA
1/150	1/150	CD	B-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	I-DNA
0.4	0.4	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
SL	SL	NN	I-NP	I-DNA
Q5MIN	Q5MIN	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Do	Do	NNP	B-NP	O
not	not	RB	O	O
administer	administer	VB	B-VP	O
if	if	IN	B-SBAR	O
receiving	receive	VBG	B-VP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
WADDY	WADDY	NNP	B-NP	O
,	,	,	O	O
CORDELL	CORDELL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NORVASC	NORVASC	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
73226725	73226725	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
EDEMA	EDEMA	NNP	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NIFEDIPINE	NIFEDIPINE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
EDEMA	EDEMA	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
meds	med	NNS	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Begin	Begin	NNP	B-NP	O
Plavix	Plavix	NNP	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
if	if	IN	B-SBAR	O
a	a	DT	B-NP	O
loading	loading	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

NOVOLOG	NOVOLOG	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
48	48	CD	I-NP	O
UNITS	UNITS	NNS	I-NP	O
SC	SC	NN	I-NP	B-protein
QAM	QAM	NN	I-NP	I-protein
LABETOLOL	LABETOLOL	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lifting	NN	I-NP	O
for	for	IN	B-PP	O
3-4	3-4	CD	B-NP	O
days	day	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Riculfy	Riculfy	NNP	I-NP	O
1-2wks	1-2wk	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
LIDOCAINE	LIDOCAINE	NN	B-NP	O
,	,	,	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
LOSARTAN	LOSARTAN	NN	B-NP	O
,	,	,	O	O
NIFEDIPINE	NIFEDIPINE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
cad	cad	VBD	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Morbid	Morbid	NNP	I-NP	O
obesity	obesity	NN	I-NP	O
HTN	HTN	NN	I-NP	O
UTI	UTI	NN	I-NP	O
Possible	Possible	JJ	I-NP	O
meningitis	meningitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
viral	viral	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
cardia	cardia	NN	I-NP	O
cath	cath	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
yo	yo	NN	I-NP	O
F.	F.	NNP	I-NP	O
Positive	Positive	JJ	I-NP	O
SPECT	SPECT	NN	I-NP	O
study	study	NN	I-NP	O
for	for	IN	B-PP	O
non-anginal	non-anginal	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Known	Know	VBN	B-VP	O
for	for	IN	B-PP	O
IDDM	IDDM	NN	B-NP	O
,	,	,	I-NP	O
HTN	HTN	NN	I-NP	B-protein
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

Via	Via	NNP	B-NP	O
Rt	Rt	NNP	I-NP	O
Radial	Radial	NNP	I-NP	O
access	access	NN	I-NP	O
,	,	,	O	O
angiogram	angiogram	NN	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
confirmed	confirm	VBN	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
mid-LAD	mid-LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
2	2	CD	B-NP	O
sequential	sequential	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
mid	mid	JJ	B-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
former	former	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
2.5	2.5	CD	B-NP	O
x28	x28	CD	I-NP	O
Cypher	Cypher	NN	I-NP	O
while	while	IN	B-SBAR	O
RCA	RCA	NN	B-NP	O
lesion	lesion	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Cypher	Cypher	NNP	I-NP	O
3.5	3.5	CD	I-NP	O
x18	x18	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
mid	mid	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
3.0	3.0	CD	B-NP	O
x23	x23	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
distal	distal	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

PCI	PCI	NN	B-NP	O
done	do	VBN	B-VP	O
under	under	IN	B-PP	O
Angiomax	Angiomax	NNP	B-NP	O
.	.	.	O	O

Radial	Radial	JJ	B-NP	O
access	access	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
postPCI	postPCI	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complication	complication	NN	I-NP	O
.	.	.	O	O

2/25/04	2/25/04	CD	B-NP	O
pt	pt	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
ready	ready	JJ	I-ADJP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
Plavix	Plavix	NNP	B-NP	O
75mg	75mg	CD	I-NP	O
everyday	everyday	NN	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
90	90	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
Aspirin	Aspirin	NN	I-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
STOP	STOP	NN	I-NP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
without	without	IN	B-PP	O
speaking	speak	VBG	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
first	first	RB	B-ADVP	O
.	.	.	O	O

Call	Call	VB	B-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
questions	question	NNS	I-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
Follow-up	Follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Urrey	Urrey	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
wks	wk	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
EHRENBERG	EHRENBERG	NNP	B-NP	O
,	,	,	O	O
FEDERICO	FEDERICO	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/22/04	10/22/04	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
39	39	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

